Glycated Albumin Market

Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy.

Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose present in diabetes meatus results in increased glycation of all proteins, including, albumin. Measurement of the amount of the glycation reaction resulting from the combination of glucose with free amino groups in proteins present in the blood is used to monitor the level of glucose that has generally been present in body fluids over a preceding period.

Thus serum glycated albumin assay can be used to determine the current level of glycation of albumin, the most abundant plasma protein. Hence, the gycated albumin assay may be used as a marker of glycemic control in diabetes and reflects glycemic control over the precious 2 to 4 weeks.

Glycated Albumin Market contains market size and forecasts of Glycated Albumin in global, including the following market information:

Global Glycated Albumin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Glycated Albumin Market Sales, 2017-2022, 2023-2028, (Kits)

Global top five Glycated Albumin companies in 2021 (%)

The global Glycated Albumin market was valued at 441.4 million in 2021 and is projected to reach US$ 608.4 million by 2028, at a CAGR of 4.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Glycated Albumin (Human) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Glycated Albumin include Asahi Kasei Pharma, DIAZYME, Abnova, LifeSpan, Exocell, BSBE, Medicalsystem, Maccura and Leadman, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glycated Albumin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Glycated Albumin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kits)

Global Glycated Albumin Market Segment Percentages, by Type, 2021 (%)

Glycated Albumin (Human)

Glycated Albumin (Animal)

Global Glycated Albumin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kits)

Global Glycated Albumin Market Segment Percentages, by Application, 2021 (%)

Hospitals and Clinics

Laboratories

Global Glycated Albumin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kits)

Global Glycated Albumin Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Glycated Albumin revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Glycated Albumin revenues share in global market, 2021 (%)

Key companies Glycated Albumin sales in global market, 2017-2022 (Estimated), (Kits)

Key companies Glycated Albumin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Asahi Kasei Pharma

DIAZYME

Abnova

LifeSpan

Exocell

BSBE

Medicalsystem

Maccura

Leadman

Simes Sikma

NINGBO PUREBIO